Importantly, our previous work and other data have shown that GSTZ1‐1 is downregulated in (HCC) and that it plays a tumour suppressor role in HCC progression by inhibiting the NRF2/IGF1R axis 11, 12. This evidence concerns the gene IGF1R and hepatocellular carcinoma.